Puni naziv projekta: Pan-European Breast Image Platform for Advanced AI-based Breast Cancer Screening (BreastSCan)
Koordinator: European Institute for Biomedical Imaging Research (EIBIR)
Trajanje projekta: 1. rujna 2025. – 31. kolovoza 2029.
Ukupan iznos bespovratnih sredstava: 4.572.072,55 EUR
Sufinanciranje Europske unije: 3.657.658,05 EUR
Program financiranja: EU4Health Programme 2021–2027
Ugovor o dodjeli bespovratnih sredstava br.: 101219312
Broj partnera: 20
Sudjelujuće zemlje: Austrija, Italija, Španjolska, Belgija, Hrvatska, Švedska, Malta, Grčka i Mađarska
Rak dojke najčešći je oblik raka među ženama u Europi, a rano otkrivanje ključno je za spašavanje života. Napredak digitalnih tehnologija i umjetne inteligencije (AI) danas otvara nove mogućnosti za precizniji, učinkovitiji i dostupniji probir na rak dojke.
Projekt BreastSCan okuplja vodeće bolnice, istraživačke centre i tehnološke partnere diljem Europe s ciljem iskorištavanja tih mogućnosti. Klinička bolnica Dubrava sudjeluje u projektu BreastSCan kao jedan od partnerskih kliničkih centara i pružatelja podataka u Republici Hrvatskoj. Tijekom projekta planira se prikupiti više od milijun snimaka dojki od 20 partnera iz devet zemalja, s ciljem stvaranja jedne od najvećih i najraznovrsnijih baza podataka te vrste u Europi.
Prikupljeni će se podaci integrirati u Cancer Image Europe platformu, u sklopu European Cancer Imaging Initiative, što će omogućiti razvoj i testiranje naprednih AI alata za bržu, točniju i personaliziraniju dijagnostiku raka dojke.
Projekt dodatno doprinosi standardizaciji kvalitete snimanja, sigurnoj razmjeni podataka te edukaciji zdravstvenih djelatnika o primjeni digitalnih tehnologija i umjetne inteligencije u kliničkoj praksi, s ciljem poboljšanja ranog otkrivanja i ishoda liječenja raka dojke diljem Europe.
Više informacija
Izjava o sufinanciranju i odricanju od odgovornosti : Projekt BreastSCan sufinanciran je u okviru programa EU4Health 2021.–2027. prema ugovoru o dodjeli bespovratnih sredstava br. 101219312. financira Europska unija. Izneseni stavovi i mišljenja isključivo su stavovi autora i ne odražavaju nužno stavove Europske unije ili Europske izvršne agencije za zdravlje i digitalne tehnologije (HaDEA). Ni Europska unija ni tijelo koje dodjeljuje bespovratna sredstva ne mogu se smatrati odgovornima za njih.
BreastSCan Project
Full Project Title: Pan-European Breast Image Platform for Advanced AI-based Breast Cancer Screening (BreastSCan)
Coordinator: European Institute for Biomedical Imaging Research (EIBIR)
Project Duration: 1 September 2025 – 31 August 2029
Total Grant Amount: €4,572,072.55
EU Funding: €3,657,658.05
Funding Programme: EU4Health Programme 2021–2027
Grant Agreement No.: 101219312
Participating Countries: Austria, Italy, Spain, Belgium, Croatia, Sweden, Malta, Greece, and Hungary
Breast cancer is the most common cancer among women in Europe, and early detection is key to saving lives. Advances in digital technologies and artificial intelligence (AI) are creating new opportunities to make breast cancer screening more accurate, efficient, and accessible.
The BreastSCan project brings together leading hospitals, research centres, and technology partners across Europe to harness these opportunities. University Hospital Dubrava participates in the BreastSCan project as one of the partner clinical centres and data providers in the Republic of Croatia. During the project, more than one million breast images will be collected from 20 partners across nine countries, creating one of the largest and most diverse breast imaging datasets of its kind in Europe.
The collected data will be integrated into the Cancer Image Europe platform within the European Cancer Imaging Initiative, enabling the development and testing of advanced AI tools for faster, more accurate, and more personalised breast cancer diagnosis.
The project further contributes to the standardisation of imaging quality, secure data sharing, and training of healthcare professionals in the use of digital technologies and artificial intelligence in clinical practice, with the goal of improving early detection and treatment outcomes for breast cancer patients across Europe.
More information:
Mandatory Disclaimer: BreastSCan is co-funded under the EU4Health Programme 2021–2027 under grant agreement no. 101219312. Funded by the European Union. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.